Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03393819
Other study ID # RP-002-01072013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 29, 2014
Est. completion date April 6, 2016

Study information

Verified date June 2019
Source Lakehead University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.


Description:

Post-operative infections, although rare, can lead to significant patient morbidity and cost. A potential risk factor for the development of post-operative wound infection is the amount of bacterial skin flora present at the operative site at the time of surgery. Therefore, the use of an effective anti-microbial preoperative skin-preparation solution is essential in preventing the contamination of the surgical site and in turn the surgical wound.

Several different types of anti-microbial skin preparation solutions are presently used pre-operatively. However, there is currently no consensus on which solution is superior. Previous studies have investigated the efficacy of commonly used solutions in the shoulder, foot and spine, however the bacterial flora from these areas are likely different from the hip region. Thus the findings in the literature are not necessarily applicable to surgery involving the hip.

Because of the potentially devastating consequences of a surgical wound infection, ensuring effective skin preparation prior to surgery is critical. Therefore the identification of a superior skin-preparation solution for the elimination of bacterial pathogens, specific to the hip region, could potentially have considerable impact on the clinical care of patients undergoing hip arthroplasty surgery.

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol), at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.The primary outcome is as follows: positive culture rates of residual bacteria following surgical skin preparation. Secondary outcomes that will be evaluated is culture rates post-surgery (following skin closure) and acute (within 3 months) post-operative wound complications.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date April 6, 2016
Est. primary completion date January 7, 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Has consented for primary total hip arthroplasty by any of the following orthopaedic surgeons: Drs. Kurt Droll, Dave Puskas or Claude Cullinan

- Are capable of providing their own consent

- Are able to adequately communicate in English to undergo informed consent

- Has provided written, informed consent for the study

Exclusion Criteria:

- Previous hip arthroplasty

- Evidence of an open wound at the incision site

- Evidence of an abrasion in the vicinity of the planned incision

- Evidence of an active infection at or near the surgical site

- Evidence of an active infection elsewhere in the body

- Are chronically immunosuppressed e.g. transplant

- Is deemed not suitable for the study in the opinion of an investigator

Study Design


Intervention

Drug:
DuraPrep
DuraPrep surgical solution
ChloraPrep
ChloraPrep surgical solution

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Lakehead University Thunder Bay Regional Health Sciences Centre

Outcome

Type Measure Description Time frame Safety issue
Primary Post-preparation skin swab bacterial culture rates following surgical skin preparation 4 minutes post-skin preparation
Secondary Post-operative skin swab bacterial culture rates following surgery immediately after closure of the incision, before drape is removed from operative site
Secondary Post-operative wound complications wound complications at follow-up 3 months post-surgery
See also
  Status Clinical Trial Phase
Completed NCT02580214 - Immunonutrition in Total Hip Arthroplasty Phase 2/Phase 3
Completed NCT02839876 - Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty Phase 4
Recruiting NCT06107296 - Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study
Recruiting NCT03806114 - Dislocation Precautions N/A
Completed NCT02342236 - Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty N/A
Completed NCT01514006 - Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty N/A
Completed NCT02338661 - Clinical Observation Study With the SBG Stem